Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Irritable Bowel Syndrome, July 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 79 articles: HTML format

Single Articles

1. BASMISIRLI E, Kip M, Altun H, Inanc N, et al
   Evaluating the Quality and Reliability of YouTube Videos Providing Nutritional Recommendations for Irritable Bowel Syndrome.
   J Hum Nutr Diet. 2025;38:e70088.
   PubMed    
   Abstract available
   
   

2. TANG Y, Liu Z, Wu X, He Z, et al
   EXPRESS: The Involvement of Spinal lncRNA RT1-CE10 in Chronic Functional Visceral Pain.
   Mol Pain. 2025 Jul 3:17448069251358692. doi: 10.1177/17448069251358692.
   PubMed    
   Abstract available
   
   

3. YUAN S, Bai M, Sun H
   Letter to the editor: the causal effects of primary biliary cholangitis on irritable bowel syndrome a mendelian randomization study.
   Int J Surg. 2025 Jul 2. doi: 10.1097/JS9.0000000000002802.
   PubMed    
   
   
   

4. ROSSI CM, Merli S, Lenti MV, De Amici M, et al
   Clinical and atopic features of patients with wheat allergy dependent on augmentation factors (WALDA) presenting with urticaria: a monocentric study.
   Eur Ann Allergy Clin Immunol. 2025 Jul 3. doi: 10.23822/EurAnnACI.1764-1489.
   PubMed    
   Abstract available
   
   

5. SUN N, Cao LS, Xia WY, Wang JM, et al
   Gut sensory neurons as regulators of neuro-immune-microbial interactions: from molecular mechanisms to precision therapy for IBD/IBS.
   J Neuroinflammation. 2025;22:172.
   PubMed    
   Abstract available
   
   

6. YAO G, Zhou Y, Jin J, Zhou P, et al
   Adding a C-terminal amino acid prevents the conformational interconversion of plecanatide analogues.
   Chembiochem. 2025 Jul 2:e202500237. doi: 10.1002/cbic.202500237.
   PubMed    
   Abstract available
   
   

7. DING X, Li T, Zhao J, Fan M, et al
   Legume seed coat polysaccharides: Extraction, physicochemical properties, and anti-inflammatory potential against intestinal inflammation-A review.
   Int J Biol Macromol. 2025 Jun 30:145662. doi: 10.1016/j.ijbiomac.2025.145662.
   PubMed    
   Abstract available
   
   

8. SUN Y, Wu D, Lu L, Wang J, et al
   Mesenchymal stem cell-derived apoptotic vesicles regulate irritable bowel syndrome in mice via the 5-HT brain-gut axis.
   Stem Cell Res Ther. 2025;16:326.
   PubMed    
   Abstract available
   
   

9. BERTALAN E, Horvath Z, Gajdos P, Magyarodi T, et al
   Psychometric properties of the Hungarian Visceral Sensitivity Index (VSI-H): insights from two cross-sectional studies on self-reported IBS and gluten-related conditions.
   BMC Psychol. 2025;13:679.
   PubMed    
   Abstract available
   
   

10. SHANKAR R, Yip AW
    Sentiment analysis and topic modeling of social media data to explore public discourse on irritable bowel syndrome.
    Sci Rep. 2025;15:21550.
    PubMed    
    Abstract available
    
    

11. SILVA H, Porter J, Barrett J, Gibson PR, et al
    Dietary Intake, Symptom Control and Quality of Life After Dietitian-Delivered Education on a FODMAP Diet for Irritable Bowel Syndrome: A 7-Year Follow Up.
    Neurogastroenterol Motil. 2025 Jul 1:e70116. doi: 10.1111/nmo.70116.
    PubMed    
    Abstract available
    
    

12. NEWTON JM, Edwards WJS, Thompson GS, Gentekaki E, et al
    Effect of antibiotic administration on Blastocystis persistence and gut microbiome-metabolome dynamics in an irritable bowel syndrome longitudinal case study.
    Access Microbiol. 2025;7:000926.
    PubMed    
    Abstract available
    
    

13. DESAI BJ, Person H
    A Practical Approach to Functional Abdominal Pain and Irritable Bowel Syndrome in Children and Adolescents.
    Adv Pediatr. 2025;72:219-234.
    PubMed    
    Abstract available
    
    

14. FUKUSHIMA T, Okamoto T, Hamaya T, Kodama H, et al
    Serum Serotonin Levels as a Potential Risk Factor for Overactive Bladder in a Community-Dwelling Population: A Four-Year Longitudinal Study.
    Low Urin Tract Symptoms. 2025;17:e70019.
    PubMed    
    Abstract available
    
    

15. YANG Y, Sui J, Liao W, Wang S, et al
    Clinical Evidence on the Health Benefits and Safety of Probiotic Lacticaseibacillus rhamnosus: A Systematic Review.
    Probiotics Antimicrob Proteins. 2025 Jul 11. doi: 10.1007/s12602-025-10646.
    PubMed    
    Abstract available
    
    

16. FLAHERTY A, Tomlinson E, Weaver B, Akhbari B, et al
    Factors Associated with Non-Unions of Fifth Metatarsal Fractures.
    Arch Bone Jt Surg. 2025;13:367-377.
    PubMed    
    Abstract available
    
    

17. WANG M, Tan Y, Guo H, Peng H, et al
    Sex hormone-binding globulin and sex-specific association between irritable bowel syndrome and type 2 diabetes: a prospective cohort study.
    Nutr J. 2025;24:108.
    PubMed    
    Abstract available
    
    

18. ZHAI L, Zheng Y, Lo CW, Xu S, et al
    Butyrate-producing commensal bacteria mediates the efficacy of herbal medicine JCM-16021 on abdominal pain in diarrhea-predominant irritable bowel syndrome: a randomized clinical trial.
    Phytomedicine. 2025;145:157040.
    PubMed    
    Abstract available
    
    

19. ROSSI CM, Lenti MV, Di Sabatino A
    Mechanistic Gaps in Linking Aero- and Food Allergens to Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 Jul 10:e70122. doi: 10.1111/nmo.70122.
    PubMed    
    
    
    

20. MORANO D, Scarlata GGM, Spagnuolo R, Suraci E, et al
    [Functional disorders of the upper digestive tract: epidemiological, clinical and therapeutic aspects.].
    Recenti Prog Med. 2025;116.
    PubMed    
    Abstract available
    
    

21. HADI HS, Ali Hadi M, Aljuranii LA, Al-Fahham AA, et al
    Respiratory dysfunction in patients with irritable bowel syndrome.
    Pol Merkur Lekarski. 2025;53:347-351.
    PubMed    
    Abstract available
    
    

22. ARIF TB, Damianos JA, Rahman AU, Hasnain N, et al
    Fecal Microbiota Transplantation for Disorders of Gut-Brain Interaction: Current Insights, Effectiveness, and Future Perspectives.
    Curr Gastroenterol Rep. 2025;27:50.
    PubMed    
    Abstract available
    
    

23. BURKADZE A, Burkadze E, Kandashvili T, Silagadze T, et al
    Factor Analysis of the BDI-II and HAMD-21 in Patients With Irritable Bowel Syndrome.
    Alpha Psychiatry. 2025;26:44020.
    PubMed    
    Abstract available
    
    

24. MINE K, Murata Y, Fujino M, Fujino T, et al
    A Refractory, Gas-Predominant Subgroup of Irritable Bowel Syndrome Markedly Improved With Relatively Long-Term Paroxetine Treatment: A Preliminary Study.
    Cureus. 2025;17:e85494.
    PubMed    
    Abstract available
    
    

25. SALMELA E, Kalle K, Lindfors K, Saavalainen P, et al
    Long-term health outcomes of people without celiac disease avoiding gluten consumption: a 25-year prospective cohort study.
    Eur J Clin Nutr. 2025 Jul 8. doi: 10.1038/s41430-025-01641.
    PubMed    
    Abstract available
    
    

26. GWEE KA
    "Ulcerative Colitis and Irritable Bowel Syndrome Are Diagonally Opposite." Missing the Trees for the Woods.
    J Neurogastroenterol Motil. 2025;31:289-290.
    PubMed    
    
    
    

27. KESHAVARZI A, Talebi SS, Ahmadpanah M, Soltanian A, et al
    Sexual function, depression, and quality of life in patients with irritable bowel syndrome.
    BMC Gastroenterol. 2025;25:504.
    PubMed    
    Abstract available
    
    

28. REYES-DIAZ SA, Priego-Parra BA, Ordaz-Alvarez HR, Nunez-Jimenez EL, et al
    Unequal burdens: Irritable bowel syndrome in sexual and gender minority communities vs cisgender heterosexual individuals.
    Clin Transl Gastroenterol. 2025 Jul 7. doi: 10.14309/ctg.0000000000000883.
    PubMed    
    Abstract available
    
    

29. PONIEWIERKA E, Szura E, Valach P
    Effects of physical activity on symptoms of irritable bowel syndrome.
    Prz Gastroenterol. 2025;20:173-177.
    PubMed    
    Abstract available
    
    

30. BAI X, Ihara E, Tanaka Y, Minoda Y, et al
    The interplay of gut microbiota and intestinal motility in gastrointestinal function.
    J Smooth Muscle Res. 2025;61:51-58.
    PubMed    
    Abstract available
    
    

31. SUMBIZI C, Hassan O, Ng'wanasayi M, Ngimba C, et al
    Rectosigmoid endometriosis, a rare cause of lower GI bleeding in a premenopausal woman: Case report.
    Int J Surg Case Rep. 2025;133:111608.
    PubMed    
    Abstract available
    
    

32. LIU Q, Fang W, Zheng P, Xie S, et al
    Multi-kingdom microbiota analysis reveals bacteria-viral interplay in IBS with depression and anxiety.
    NPJ Biofilms Microbiomes. 2025;11:129.
    PubMed    
    Abstract available
    
    

33. MINA S, Daher S, Jamal Elddin S, Mina N, et al
    Post-infectious irritable bowel syndrome in a paediatric population: first data in a Middle Eastern country.
    BMC Pediatr. 2025;25:531.
    PubMed    
    Abstract available
    
    

34. LI J, Zhang K, Yan F, Wang Y, et al
    Aptamer-chitosan modified chlorogenic acid derived nanoparticles for enhancing target treatment in diarrhea-predominant irritable bowel syndrome.
    Int J Biol Macromol. 2025;320.
    PubMed    
    Abstract available
    
    

35. MANNILA E, Hokkanen L, Ahonen E, Turpeinen AM, et al
    Tolerance of protein hydrolyzed lactose-free A1 milk and A2 milk in lactose-tolerant and lactose-intolerant volunteers - a randomized cross-over trial with two parallel groups.
    J Dairy Sci. 2025 Jul 2:S0022-0302(25)00476-X. doi: 10.3168/jds.2025-26712.
    PubMed    
    Abstract available
    
    

36. PECYNA P, Bykowska-Derda A, Gabryel M, Mankowska-Wierzbicka D, et al
    Blautia spp. in the gut microbiome: Its relation to dietary choices and to the nutritional status of patients with irritable bowel syndrome.
    Nutrition. 2025;138:112836.
    PubMed    
    Abstract available
    
    

37. DELI F, Whelan K, Bear DE
    Nutritional adequacy in critically ill adults receiving noninvasive ventilation: A descriptive cohort study.
    JPEN J Parenter Enteral Nutr. 2025 Apr 23. doi: 10.1002/jpen.2764.
    PubMed    
    Abstract available
    
    

38. ROBERTSON K, Hahn O, Tantry A, Robinson BG, et al
    Gpr37 modulates the severity of inflammation-induced GI dysmotility by regulating enteric reactive gliosis.
    iScience. 2025;28:112885.
    PubMed    
    Abstract available
    
    

39. GANZEVOORT IN, Berger MY, Benninga MA, Vlieger AM, et al
    Using media to enhance paediatric patient recruitment for research in primary care.
    Prim Health Care Res Dev. 2025;26:e62.
    PubMed    
    Abstract available
    
    

40. 
    Unraveling the genetic susceptibility of irritable bowel syndrome: integrative genome-wide analyses in 845,492 individuals: a diagnostic study: Erratum.
    Int J Surg. 2025;111:4971.
    PubMed    
    
    
    

41. CHEN D, Ni D, Yang H
    Combination therapy with otilonium bromide and trimebutine maleate demonstrates significant clinical advantages in irritable bowel syndrome patients.
    Am J Transl Res. 2025;17:4859-4866.
    PubMed    
    Abstract available
    
    

42. SKELTON M, Mitchell BL, Assary E, Li D, et al
    Genome-wide insights into generalised anxiety using a dimensional symptom severity approach.
    medRxiv [Preprint]. 2025 Jul 11:2025.07.10.25331321.
    PubMed    
    Abstract available
    
    

43. ATAYA J, Swileh N, Alchawa Z, Kabboul H, et al
    Exploring the relationship between irritable bowel syndrome and psychosocial, demographic, and health factors in Syrian hospital settings.
    BMC Psychiatry. 2025;25:708.
    PubMed    
    Abstract available
    
    

44. LI K, Chu H, Zou L, Ruan J, et al
    [Effect of moxibustion on small intestinal mucosal immune barrier in rats with diarrhea-predominant irritable bowel syndrome].
    Zhongguo Zhen Jiu. 2025;45:935-944.
    PubMed    
    Abstract available
    
    

45. RIDGE A, Cooling N, Seidel B
    A mixed immediate and delayed allergy to oral vitamin D supplementation: a case report.
    J Med Case Rep. 2025;19:344.
    PubMed    
    Abstract available
    
    

46. KIM HJ, Jeon HJ, Kang WS, Choi JW, et al
    Awareness of Psychosomatic Medicine in Korea: Results From an Online Survey Conducted With Doctors and the General Public.
    J Korean Med Sci. 2025;40:e138.
    PubMed    
    Abstract available
    
    

47. PIVA SR, Smith C, Anderst W, Bell KM, et al
    Demographic and Biomedical Characteristics of an Observational Cohort With Chronic Low Back Pain: A Descriptive Analysis.
    JOR Spine. 2025;8:e70094.
    PubMed    
    Abstract available
    
    

48. QI T, Wang Y, Liu Y, Li W, et al
    Bacteria into bloodstream caused by oral probiotics based on whole genome sequencing: A case report.
    Medicine (Baltimore). 2025;104:e43337.
    PubMed    
    Abstract available
    
    

49. CRENN P
    The sick gut with diarrhea: FODMAPS for treatment?
    Curr Opin Clin Nutr Metab Care. 2025 Jul 8. doi: 10.1097/MCO.0000000000001141.
    PubMed    
    Abstract available
    
    

50. BJORKEVOLL SMG, Randulff Hillestad EM, Lied GA, Teige ES, et al
    A 12-Week Strict Low FODMAP Diet Reduces the Severity Levels of Fatigue, Depression, Anxiety, and Inattention in Patients with Irritable Bowel Syndrome.
    Curr Dev Nutr. 2025;9:107483.
    PubMed    
    Abstract available
    
    

51. GALVEZ A, Kuhlmann P, Barker M, Chen A, et al
    Association of HRQOL with Symptom Patterns in an Online Cohort of Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Urology. 2025 Jul 10:S0090-4295(25)00629-6. doi: 10.1016/j.urology.2025.
    PubMed    
    Abstract available
    
    

52. CHOJNACKI M, Blonska A, Kaczka A, Chojnacki J, et al
    Assessment of the Gut Microbiome in Patients with Coexisting Irritable Bowel Syndrome and Chronic Fatigue Syndrome.
    Nutrients. 2025;17:2232.
    PubMed    
    Abstract available
    
    

53. ROHNER S, Schnepper R, Meinlschmidt G, Schaefert R, et al
    Basel Long COVID Cohort Study (BALCoS): protocol of a prospective cohort study.
    BMJ Open. 2025;15:e093981.
    PubMed    
    Abstract available
    
    

54. GOYAL O, Goyal MK, Gupta A, Batta S, et al
    Self-Reported Food Triggers and Food Fears Impact Nutrient Intake and Quality of Life in Patients with Irritable Bowel Syndrome and Functional Dyspepsia.
    Korean J Gastroenterol. 2025;85:345-356.
    PubMed    
    Abstract available
    
    

55. SHAHROKH S, Namazi N, Abbasinazari M, Abazarikia A, et al
    Assessment of the Efficacy and Safety of Sublingual Melatonin on Symptom Severity, Quality of Life, and Sleep Disorders in Patients with Irritable Bowel Syndrome.
    Iran J Pharm Res. 2025;24:e156425.
    PubMed    
    Abstract available
    
    

56. SEILER CL, Rueda GH, Miranda PM, Nardelli A, et al
    Effect of gluten and wheat on symptoms and behaviours in adults with irritable bowel syndrome: a single-centre, randomised, double-blind, sham-controlled crossover trial.
    Lancet Gastroenterol Hepatol. 2025 Jul 18:S2468-1253(25)00090.
    PubMed    
    Abstract available
    
    

57. ELSENBRUCH S
    Unravelling the power of nocebo in symptom response to food challenge in irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2025 Jul 18:S2468-1253(25)00126.
    PubMed    
    
    
    

58. BAIDOO N, Sanger GJ
    The Ageing of the Human Lower Bowel.
    Br J Hosp Med (Lond). 2025;86:1-16.
    PubMed    
    Abstract available
    
    

59. XIONG J, Xu T, Wang Z, Huang Y, et al
    The hidden genetic and microbial networks connecting neuropsychiatric and digestive disorders.
    Comput Struct Biotechnol J. 2025;27:3114-3126.
    PubMed    
    Abstract available
    
    

60. SAMUELS THA, Warrell CE
    Travellers' diarrhoea - solidifying our knowledgebase.
    Curr Opin Infect Dis. 2025 Jul 24. doi: 10.1097/QCO.0000000000001131.
    PubMed    
    Abstract available
    
    

61. GAUTAM M, Goel U, Bader A, Azim S, et al
    Patterns of prescription and discontinuation of glucagon-like peptide-1 receptor agonists among patients with irritable bowel syndrome.
    Ann Gastroenterol. 2025;38:420-427.
    PubMed    
    Abstract available
    
    

62. TEPERIKIDIS L, Mademlis C, Hatzinakos G, Lazaridis N, et al
    Replication and extension of a meta-analysis of antidepressants for irritable bowel syndrome: a comparison of odds ratios and risk ratios using artificial intelligence-powered tools.
    Ann Gastroenterol. 2025;38:462-463.
    PubMed    
    
    
    

63. SMITH JS, Coffey MJ, Jaffe A, Chuang S, et al
    Disorders of Gut-Brain Interaction in a Pediatric Cystic Fibrosis Cohort.
    Pediatr Pulmonol. 2025;60:e71214.
    PubMed    
    Abstract available
    
    

64. WIERZBICKA A, Khaidakov B, Zakerska-Banaszak O, Andrzejewska P, et al
    Effects of a polyphenol-rich extract blend, probiotics, and hydrolyzed fiber on quality of life and gut health markers in patients with irritable bowel syndrome-A randomized, double-blind, placebo-controlled trial.
    Front Nutr. 2025;12:1603011.
    PubMed    
    Abstract available
    
    

65. VAN DEN BELT M, Liu Z, Janssen Duijghuijsen L, Zoetendal EG, et al
    Randomised controlled trial: nutritional supplements to relieve irritable bowel syndrome symptoms by targeting the gut microbiota.
    J Nutr Sci. 2025;14:e46.
    PubMed    
    Abstract available
    
    

66. FIESS A, Hartmann A, Ernst M, Schuster AK, et al
    Sequelae of preterm birth over the lifespan: an exploratory analysis of behavioral problems in childhood and increased risk of major depression and anxiety in adulthood from a cohort study.
    EClinicalMedicine. 2025;85:103316.
    PubMed    
    Abstract available
    
    

67. SOGAME M, Ito M
    Advanced multidimensional quality evaluation of encapsulated peppermint oil products in various formulas.
    J Nat Med. 2025 Jul 18. doi: 10.1007/s11418-025-01934.
    PubMed    
    Abstract available
    
    

68. BAILLIE S, Saxena S, Jayasooriya N, Bottle A, et al
    Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study.
    Aliment Pharmacol Ther. 2025 Jul 2. doi: 10.1111/apt.70247.
    PubMed    
    Abstract available
    
    

69. BANNON CA, Walters JRF, Wu T, Kay RG, et al
    Insulin-like peptide 5 is released in response to bile acid in the rectum and is associated with diarrhoea severity in patients with bile acid diarrhoea.
    Gut. 2025 Jul 23:gutjnl-2025-335393. doi: 10.1136/gutjnl-2025-335393.
    PubMed    
    Abstract available
    
    

70. GOYAL MK, Goyal O, Sood A
    The road to Rome IV and beyond: Evolution, refinements and future considerations for the Rome criteria for functional gastrointestinal disorders.
    Indian J Gastroenterol. 2025 Jul 4. doi: 10.1007/s12664-025-01808.
    PubMed    
    Abstract available
    
    

71. YAN Y, Wang LJ, Shen XJ
    Comment on "Prevalence of Eating Disorders Among Adults With Irritable Bowel Syndrome".
    J Clin Gastroenterol. 2025 Jul 7. doi: 10.1097/MCG.0000000000002223.
    PubMed    
    
    
    

72. TALLEY NJ, Duncanson K, Williams GM
    Why are disorders of gut-brain interaction (DGBI) often food-related? Duodenal eosinophils and mast cells, small intestinal bacteria, food allergy and altered food intake in functional dyspepsia and the irritable bowel syndrome: a new paradigm.
    J Gastroenterol. 2025 Jun 30. doi: 10.1007/s00535-025-02268.
    PubMed    
    Abstract available
    
    

73. YAO Y, You X, Yang S, Xie Y, et al
    Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study.
    J Gastroenterol Hepatol. 2025 Jul 12. doi: 10.1111/jgh.70002.
    PubMed    
    Abstract available
    
    

74. YAN Y, Liu L, Shen XJ
    Comment on "Impact of Positive Glucose, Lactose, and Fructose Hydrogen Breath Tests on Symptoms and Quality of Life in Irritable Bowel Syndrome".
    J Gastroenterol Hepatol. 2025 Jul 23. doi: 10.1111/jgh.70032.
    PubMed    
    
    
    

75. GANZEVOORT IN, Berger MY, Vlieger AM, Benninga MA, et al
    Children with disorders of gut-brain interaction in primary care versus hospital care: A comparison of characteristics.
    J Pediatr Gastroenterol Nutr. 2025 Jun 29. doi: 10.1002/jpn3.70129.
    PubMed    
    Abstract available
    
    

76. CRISTOFORI F, Calabrese FM, Iacobellis I, Santamaria M, et al
    Calcium butyrate efficacy in pediatric irritable bowel syndrome: Randomized placebo-controlled multiomics-based clinical trial.
    J Pediatr Gastroenterol Nutr. 2025 Jul 9. doi: 10.1002/jpn3.70154.
    PubMed    
    Abstract available
    
    

77. BEINVOGL B, Burch E, Snyder J, Liu E, et al
    Vulnerability factors for pediatric disorders of gut-brain interaction and implications for functional impairment.
    J Pediatr Gastroenterol Nutr. 2025 Jul 14. doi: 10.1002/jpn3.70155.
    PubMed    
    Abstract available
    
    

78. ROTH B, Al-Shareef D, Ohlsson B
    Intake of fiber and micronutrients in patients with IBS.
    Scand J Gastroenterol. 2025 Jul 22:1-12. doi: 10.1080/00365521.2025.2535721.
    PubMed    
    Abstract available
    
    

79. EKMAN L, Tufvesson H, Englund E, Dahlin LB, et al
    Symptoms and objective signs of peripheral sensory neuropathy in POTS and correlations to gastrointestinal symptoms.
    PLoS One. 2025;20:e0327549.
    PubMed    
    Abstract available